A case report of sofosbuvir and daclatasvirto treat a patient with acute hepatitis C virus genotype 2 monoinfection

RATIONALE: Direct-acting antivirals (DAAs) are the first-line treatment for patients with chronic hepatitis C virus (HCV) infection. However, its effects on patients with acute HCV infection are poorly understood, and the data for treatment of DAAs for genotype 2 acute monoinfection patients with HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chen, Hu, JinHua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908610/
https://www.ncbi.nlm.nih.gov/pubmed/29642211
http://dx.doi.org/10.1097/MD.0000000000010416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908610/
https://www.ncbi.nlm.nih.gov/pubmed/29642211
http://dx.doi.org/10.1097/MD.0000000000010416

Ejemplares similares